MedTrace Logo

Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers

NCT05561621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-06-15

No results posted yet for this study

Summary

The investigator will set up a study evaluating vocal biomarkers in people with MS in order to identify persons with non-motor symptoms: depression, cognitive deterioration, and fatigue. Up to now, to the best of the investigator's knowledge, there is no study reporting the use of vocal biomarkers to predict these three non-motor symptoms in people with MS.

Conditions

Interventions

OTHER

Voice analysis

Voice analysis

Sponsors & Collaborators

  • Audeering GMBH

    collaborator INDUSTRY

  • Biogen

    collaborator INDUSTRY

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Helly Hammer · Inselspital, University Hospital Bern

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-15
Primary Completion
2022-12-20
Completion
2022-12-20

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05561621 on ClinicalTrials.gov